(Q42876715)

9 November 2017

title

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate (English)

1 reference

9 November 2017

1 reference

5

1 reference

9 November 2017

23

Rino Rappuoli

1 reference

9 November 2017

22

Peter H Seeberger

1 reference

9 November 2017

Anna Kabanova

1

1 reference

9 November 2017

Immaculada Margarit

2

1 reference

9 November 2017

Francesco Berti

3

1 reference

9 November 2017

Maria R Romano

4

1 reference

9 November 2017

Giuliano Bensi

6

1 reference

9 November 2017

Emiliano Chiarot

7

1 reference

9 November 2017

Daniela Proietti

8

1 reference

9 November 2017

Erwin Swennen

9

1 reference

9 November 2017

Emilia Cappelletti

10

1 reference

9 November 2017

Paola Fontani

11

1 reference

9 November 2017

Daniele Casini

12

1 reference

9 November 2017

Roberto Adamo

13

1 reference

9 November 2017

Vittoria Pinto

14

1 reference

9 November 2017

David Skibinski

15

1 reference

9 November 2017

Sabrina Capo

16

1 reference

9 November 2017

Giada Buffi

17

1 reference

9 November 2017

Marilena Gallotta

18

1 reference

9 November 2017

William J Christ

19

1 reference

9 November 2017

A Stewart Campbell

20

1 reference

9 November 2017

John Pena

21

1 reference

9 November 2017

Paolo Costantino

24

1 reference

9 November 2017

language of work or name

English

0 references

publication date

24 September 2010

1 reference

9 November 2017

1 reference

9 November 2017

volume

29

1 reference

9 November 2017

issue

1

1 reference

9 November 2017

page(s)

104-114

1 reference

The pathogenesis of streptococcal infections: from tooth decay to meningitis

9 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Bivalency and epitope specificity of a high-affinity IgG3 monoclonal antibody to the Streptococcus group A carbohydrate antigen. Molecular modeling of a Fv fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cell-wall polysaccharide of group A streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

The Use of Streptococcal Antigens to Probe the Mechanisms of Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Pathogenesis of group A streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

A serological differentiation of human and other groups of hemolytic streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Automated solid-phase synthesis of oligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Immunochemical characterization of polyclonal and monoclonal Streptococcus group A antibodies by chemically defined glycoconjugates and synthetic oligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Ultraviolet spectrophotometric determination of hexoses, pentoses, and uronic acids after their reactions with concentrated sulfuric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Performance of high-throughput DNA quantification methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

A spectrophotometric assay for soluble and immobilized N-hydroxysuccinimide esters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Assay of reducing sugars in the nanomole range with 2,2'-bicinchoninate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Preparative purification of soybean agglutinin by affinity chromatography and its immobilization for polysaccharide isolation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

THE DETERMINATION OF ANTIBODY TO GROUP A STREPTOCOCCAL POLYSACCHARIDE IN HUMAN SERA BY HEMAGGLUTINATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

DETECTION OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODIES IN HUMAN SERA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Antibody-mediated neuronal cell signaling in behavior and movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Synthetic GPI array to study antitoxic malaria response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Tools for glycomics: mapping interactions of carbohydrates in biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.09.018

1 reference

release_2ejpx7jfwvg3thnjyibkihtmqm

9 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ejpx7jfwvg3thnjyibkihtmqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference